Amyris Announces Agreements For Up to $95 Million In Equity Financing And In-Process Initiative To Significantly Reduce Debt
EMERYVILLE, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced a series of agreements for up to $95 million in equity financing via a registered direct offering of convertible preferred …